Huifeng Bio-pharmaceutical Technology (fka HFGB)

[minimonk]

That would be up to you.

I see you like CHBT. It trades at 3 times revenues.

Assume HFGB adds the $20 million to the existing $20+ million in revenues for 2010. That's $40 million. Assume 30 million OS going forward. Use the 3 times sales and it comes to $4.00 per share.

Or see that CHBT does $1.28 EPS. Assume HFGB hits there .20 ESP. That's about 1/6 of CHBT's EPS. Translate to 1/6 of share price and HFGB value could be $2.14

And it looks like EPS will eventually move up much more than .20 with the added facility.

That's just the way I see it.

Still grossly undervalued and I will buy on dips.